Vontobel Holding
ALDX icon

Vontobel Holding’s Aldeyra Therapeutics ALDX Stock Holding History

Vontobel Holding’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,560
Closed -$104K – 1105
2023
Q3 		$104K Sell
15,560
-21,642
-58% -$161K ﹤0.01% 1018
2023
Q2 		$312K Buy
37,202
+23,770
+177% +$234K ﹤0.01% 913
2023
Q1 		$133K Buy
13,432
+3,373
+34% +$23.8K ﹤0.01% 1011
2022
Q4 		$70K Buy
+10,059
New +$57.5K ﹤0.01% 1054

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vontobel Holding's ALDX Position: Q4 2023 in Review

Vontobel Holding sold out of Aldeyra Therapeutics (ALDX) in Q4 2023, closing a stake of 15,560 shares — an estimated $104K sold.

Vontobel Holding first reported a position in ALDX in Q4 2022 and held it in 4 quarters. The position peaked at $312K in Q2 2023. 105 funds tracked by Wall St. Rank hold ALDX as of Q4 2023.

  • Vontobel Holding reported no remaining Aldeyra Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Vontobel Holding sold 15,560 Aldeyra Therapeutics shares in Q4 2023, an estimated $104K.
  • Vontobel Holding first reported a position in Aldeyra Therapeutics in Q4 2022 and held it in 4 quarters.
  • Vontobel Holding's Aldeyra Therapeutics position peaked at $312K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2023.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.